Robert Chorvat

Led the Medicinal Chemistry effort and was responsible for the conception and synthesis of the proprietary peripherally selective compounds, as well as crafting the patent applications covering these agents. Bob has more than 30 years of leadership experience in the pharmaceutical industry where he headed medicinal chemistry groups at Searle/Monsanto, DuPont Medical Products, DuPont-Merck, and DuPont Pharmaceuticals (now Bristol Meyers Squibb). Dr. Chorvat was also an adjunct professor at the University of Illinois School of Pharmacy, served on the Scientific Advisory Board of deCode Genetics (formerly MediChem Life Sciences), and as a consultant for Treventis Corp., Anakim Biologics and Academic Pharmaceuticlas, Inc. He has authored or co-authored about 40 peer-reviewed papers and three book chapters and is the inventor on about 55 issued US patents. Bob received his Ph.D. from Illinois Institute of Technology, and his Bachelor of Science degree from Illinois Benedictine College (Benedictine University).